SOLARA ACTIVE PHARMA SCIENCESSOLARA ACTIVE PHARMA SCIENCESSOLARA ACTIVE PHARMA SCIENCES

SOLARA ACTIVE PHARMA SCIENCES

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪33.69 B‬INR
−137.70INR
‪−5.67 B‬INR
‪12.74 B‬INR
‪22.38 M‬
Beta (1Y)
1.47
Employees (FY)
‪3.57 K‬
Change (1Y)
+108 +3.12%
Revenue / Employee (1Y)
‪3.57 M‬INR
Net income / Employee (1Y)
‪−1.59 M‬INR

About SOLARA ACTIVE PHA SCI LTD


CEO
Poorvank Purohit
Headquarters
Chennai
Founded
2017
ISIN
INE624Z01016
FIGI
BBG00G9GRN81
Solara Active Pharma Sciences Ltd. engages in the manufacture and development of active pharmaceutical ingredient. Its products include Albendazole, aprepitant, artesunate, brivaracetam, bumetanide, buspiron, cetirizine dihydrochloride, chlorpromazine, cinacalcet hydrochloride, citicoline sodium, colchicine, colesevelam, colestipol, cycloserine, dipyridamole, disulfiram, dolutegravir, edaravone, efinaconazole, ethacrynic acid, etomidate, felbamate, flecainide acetate, flucytosine, gabapentin, hydralazine, ibuprofen, imiquimod, indapamide, lanthanum carbonate octahydrate,levetiracetam, lurasidone, mebendazole, mefenamic acid, mesalamine, mesna, methohexital, methoxsalen, mirabegron, mycophenolate mofetil, naproxen base, nizatidine, obeticholic acid, alanzapine, patiromer sorbitex calcium, pentoxifyline, pitavastatin calcium, posaconazole, praziquantel, ranitidine, rebamipide, rifaximin, rotigotine, safinamide, sapropterin, sevelamer carbonate, succinylcholine, sucroferric oxyhydroxide, sugammadex, tioconazole, tranexamic acid and zileuton. The company was founded on February 23, 2017 and is headquartered in Chennai, India.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of SOLARA is 699.55 INR — it has decreased by −0.22% in the past 24 hours. Watch SOLARA ACTIVE PHARMA SCIENCES stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange SOLARA ACTIVE PHARMA SCIENCES stocks are traded under the ticker SOLARA.
SOLARA stock has risen by 6.29% compared to the previous week, the month change is a −18.19% fall, over the last year SOLARA ACTIVE PHARMA SCIENCES has showed a 92.50% increase.
We've gathered analysts' opinions on SOLARA ACTIVE PHARMA SCIENCES future price: according to them, SOLARA price has a max estimate of 566.00 INR and a min estimate of 566.00 INR. Watch SOLARA chart and read a more detailed SOLARA ACTIVE PHARMA SCIENCES stock forecast: see what analysts think of SOLARA ACTIVE PHARMA SCIENCES and suggest that you do with its stocks.
SOLARA reached its all-time high on May 19, 2021 with the price of 1,713.60 INR, and its all-time low was 123.05 INR and was reached on Jul 13, 2018. View more price dynamics on SOLARA chart.
See other stocks reaching their highest and lowest prices.
SOLARA stock is 3.18% volatile and has beta coefficient of 1.47. Track SOLARA ACTIVE PHARMA SCIENCES stock price on the chart and check out the list of the most volatile stocks — is SOLARA ACTIVE PHARMA SCIENCES there?
Today SOLARA ACTIVE PHARMA SCIENCES has the market capitalization of ‪33.69 B‬, it has decreased by −6.95% over the last week.
Yes, you can track SOLARA ACTIVE PHARMA SCIENCES financials in yearly and quarterly reports right on TradingView.
SOLARA ACTIVE PHARMA SCIENCES is going to release the next earnings report on Jan 30, 2025. Keep track of upcoming events with our Earnings Calendar.
SOLARA net income for the last quarter is ‪80.10 M‬ INR, while the quarter before that showed ‪−134.60 M‬ INR of net income which accounts for 159.51% change. Track more SOLARA ACTIVE PHARMA SCIENCES financial stats to get the full picture.
As of Jan 3, 2025, the company has ‪3.57 K‬ employees. See our rating of the largest employees — is SOLARA ACTIVE PHARMA SCIENCES on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SOLARA ACTIVE PHARMA SCIENCES EBITDA is ‪−1.72 B‬ INR, and current EBITDA margin is −22.18%. See more stats in SOLARA ACTIVE PHARMA SCIENCES financial statements.
Like other stocks, SOLARA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SOLARA ACTIVE PHARMA SCIENCES stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SOLARA ACTIVE PHARMA SCIENCES technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SOLARA ACTIVE PHARMA SCIENCES stock shows the buy signal. See more of SOLARA ACTIVE PHARMA SCIENCES technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.